PL2400993T3 - Sterylne roztwory kwasu hialuronowego - Google Patents

Sterylne roztwory kwasu hialuronowego

Info

Publication number
PL2400993T3
PL2400993T3 PL11702563T PL11702563T PL2400993T3 PL 2400993 T3 PL2400993 T3 PL 2400993T3 PL 11702563 T PL11702563 T PL 11702563T PL 11702563 T PL11702563 T PL 11702563T PL 2400993 T3 PL2400993 T3 PL 2400993T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
acid solutions
sterile hyaluronic
sterile
solutions
Prior art date
Application number
PL11702563T
Other languages
English (en)
Polish (pl)
Inventor
Xiaojun Michael Liu
David Joseph Heiler
Thomas Menzel
Abbie Brongo
Susan E Burke
Karl Cummins
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of PL2400993T3 publication Critical patent/PL2400993T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022Filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
PL11702563T 2010-02-09 2011-01-27 Sterylne roztwory kwasu hialuronowego PL2400993T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/702,540 US8283463B2 (en) 2010-02-09 2010-02-09 Sterile hyaluronic acid solutions
PCT/US2011/022656 WO2011100114A1 (en) 2010-02-09 2011-01-27 Sterile hyaluronic acid solutions
EP11702563.5A EP2400993B1 (en) 2010-02-09 2011-01-27 Sterile hyaluronic acid solutions

Publications (1)

Publication Number Publication Date
PL2400993T3 true PL2400993T3 (pl) 2015-06-30

Family

ID=43754892

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11702563T PL2400993T3 (pl) 2010-02-09 2011-01-27 Sterylne roztwory kwasu hialuronowego

Country Status (8)

Country Link
US (2) US8283463B2 (cg-RX-API-DMAC7.html)
EP (2) EP2400993B1 (cg-RX-API-DMAC7.html)
JP (1) JP5789271B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012019008B8 (cg-RX-API-DMAC7.html)
ES (1) ES2531955T3 (cg-RX-API-DMAC7.html)
PL (1) PL2400993T3 (cg-RX-API-DMAC7.html)
TW (1) TWI405595B (cg-RX-API-DMAC7.html)
WO (1) WO2011100114A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10189773B2 (en) 2010-05-07 2019-01-29 Medicus Biosciences, Llc In-vivo gelling pharmaceutical pre-formulation
US11083821B2 (en) * 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
ES2686114T3 (es) * 2011-12-20 2018-10-16 Angioclinic Ag El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
CA2873105C (en) 2012-05-11 2018-01-16 Medicus Biosciences, Llc Biocompatible hydrogel treatments for retinal detachment
FR3019465B1 (fr) 2014-04-02 2017-06-23 Horus Pharma Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
EP3131521B1 (en) 2014-04-17 2020-11-11 Merz Pharma GmbH & Co. KGaA Composition for improving the appearance of ageing skin
US10245324B2 (en) 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
DE102015226456A1 (de) 2015-12-22 2017-06-22 Heraeus Medical Gmbh Verfahren zur Sterilisation von wässrigen Polysaccharidlösungen und sterile wässrige Polysaccharidlösungen
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
HUE058672T2 (hu) * 2016-10-14 2022-09-28 I Com Medical Gmbh Eljárás a szemfelület homeosztázisának megállapítására, helyreállítására és megõrzésére
US12303601B2 (en) * 2017-10-12 2025-05-20 Solyplus Gmbh Methods of fabrication of concentrated and homogeneously wetted massive polymers and applications thereof
CN111196917B (zh) * 2018-11-20 2022-10-14 臧唯 内窥镜用视野清晰剂
KR20220049525A (ko) * 2019-08-21 2022-04-21 가부시키가이샤 시세이도 화장료
IT201900019724A1 (it) 2019-10-24 2021-04-24 Bmg Pharma S P A “procedimento in solvente organico per la purificazione dell’acido ialuronico sale sodico”
IT202000008299A1 (it) * 2020-04-17 2021-10-17 Glycores 2000 Srl Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare
KR102549875B1 (ko) * 2020-09-22 2023-07-03 주식회사 필코리아 필러 정제용 장치
CN112255345A (zh) * 2020-10-20 2021-01-22 山东华熙海御生物医药有限公司 一种测定高分子量透明质酸分子量的方法
KR102762718B1 (ko) * 2022-02-23 2025-02-06 주식회사 스카이테라퓨틱스 고분자 히알루론산의 구조체, 이의 제조방법 및 이를 포함하는 화장료 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
DE2837115A1 (de) 1978-08-25 1980-03-06 Bayer Ag Neues verfahren zur herstellung von sterilen feststoffen
US5093487A (en) 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
RU2067841C1 (ru) * 1994-01-28 1996-10-20 Научно-производственная фирма "Нарт" Способ получения ароматизатора
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5621093A (en) 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
WO1997033593A1 (en) * 1996-03-15 1997-09-18 Takara Shuzo Co., Ltd. A product of heat treatment of uronic acid, food, drink or drug including the product
KR19980080116A (ko) 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
US6149864A (en) 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
CH692919A5 (fr) 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
KR100354606B1 (ko) 2000-02-01 2002-09-30 주식회사 중외제약 다목적 콘택트 렌즈 관리 용액 조성물
FR2811996B1 (fr) * 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
WO2003002159A1 (en) 2001-06-29 2003-01-09 Biovitrum Ab Process for bulk autoclaving
CA2458126C (en) * 2001-11-21 2012-06-26 Novartis Ag Composition for stabilizing hyaluronic acid
DK1526859T3 (da) 2002-08-07 2013-02-04 Medidom Lab Fremgangsmåde til fremstilling af et sterilt præparat af hyaluronsyre med høj molvægt
US6930077B2 (en) 2003-09-10 2005-08-16 Advanced Medical Optics, Inc. Compositions and methods using sub-PPM combinations of polyquaternium-1 and high molecular weight PHMB
US7956180B2 (en) * 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
CN101001649B (zh) 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
DE102005030011A1 (de) 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
JP2011503047A (ja) * 2007-11-13 2011-01-27 バイオ−テクノロジー ゼネラル(イスラエル)リミテッド 粘弾性生体高分子のための希釈濾過滅菌プロセス
CN102209548A (zh) * 2008-09-15 2011-10-05 博士伦公司 包含具有氨基糖单元的聚合物的组合物及其制备和使用方法

Also Published As

Publication number Publication date
BR112012019008A2 (pt) 2015-09-15
EP2400993B1 (en) 2014-12-31
WO2011100114A1 (en) 2011-08-18
US20120295869A1 (en) 2012-11-22
US20110195925A1 (en) 2011-08-11
JP5789271B2 (ja) 2015-10-07
TW201200171A (en) 2012-01-01
TWI405595B (zh) 2013-08-21
JP2013518926A (ja) 2013-05-23
US8283463B2 (en) 2012-10-09
BR112012019008B1 (pt) 2018-11-13
EP2865395A1 (en) 2015-04-29
US8530641B2 (en) 2013-09-10
EP2400993A1 (en) 2012-01-04
BR112012019008B8 (pt) 2018-11-27
ES2531955T3 (es) 2015-03-23

Similar Documents

Publication Publication Date Title
PL2400993T3 (pl) Sterylne roztwory kwasu hialuronowego
PL2637710T3 (pl) Preparaty na bazie kwasu hialuronowego
PL2652193T3 (pl) Obróbka
EP2574362A4 (en) CATHETER
SG10201507079WA (en) Syringe
TWM389271U (en) Healthcare eyeglasses
ZA201205425B (en) Treatment with vb-201
GB201016969D0 (en) Expression system
GB201019993D0 (en) Process
EP2770936A4 (en) MEDICAL MANIPULATOR
EP2687181A4 (en) SURGICAL SYSTEM
EP2654872A4 (en) AUTODILATION CANNULA
EP2726009A4 (en) MEDICAL MANIPULATOR SYSTEM
GB201015822D0 (en) Medical ruggedised case
GB201004301D0 (en) Process
IL225835A (en) A compound with a compound
GB201013573D0 (en) Treatment
GB201004299D0 (en) Process
PL2536400T3 (pl) Lek zawierający miramistin
GB201013087D0 (en) Process
GB201014097D0 (en) Treatment
GB201018551D0 (en) Sterile hajab
GB201017535D0 (en) Sensaslim solution
GB201004368D0 (en) Blood coaggulation factors
PL391402A1 (pl) Kaniula dezintegrująco-ssąca